Optimize pediatric drug development strategies as a clinical pharmacology leader, overseeing pharmacometric analyses and regulatory submissions, while translating complex data into actionable decisions to enhance treatment efficacy and safety across global trials.

Lead the charge in driving Infigratinib's launch by engaging healthcare providers and families, leveraging your clinical expertise and strategic insight within the skeletal dysplasia community to exceed business goals and improve patient outcomes.

Lead the biostatistical strategies that support impactful medical communication efforts. Collaborate cross-functionally to provide scientific expertise, develop publication strategies, and ensure methodological rigor in all biostatistics activities.

Champion patient access and family support by navigating reimbursement challenges, providing personalized guidance, and fostering impactful collaborations for a biotech company focused on skeletal dysplasia.

Join a dynamic team as a senior leader overseeing Medical Affairs, where you'll drive scientific rigor, evidence generation, and innovative AI integration, fostering collaboration across global affiliates to improve patient outcomes in rare diseases.